Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic

Therapie. 2020 Jul-Aug;75(4):317-318. doi: 10.1016/j.therap.2020.06.002. Epub 2020 Jun 6.

Authors

Jean-Luc Cracowski¹, Mathieu Molimard², Vincent Richard³

Affiliations

¹ Université Grenoble Alpes, centre régional de pharmacovigilance et CIC1406, INSERM, HP2, 38000 Grenoble, France. Electronic address: jean-luc.cracowski@univ-grenoble-alpes.fr.
² Service de pharmacologie médicale, University Bordeaux, INSERM U1219, 33076 Bordeaux, France.
³ Université de Rouen Normandie, UNIROUEN, CHU de Rouen Normandie, service de pharmacologie, UMR Inserm U1096 EnVI, 76000 Rouen, France.

No abstract available

Publication types

Editorial

MeSH terms

COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Coronavirus Infections / epidemiology*
France
Humans
Information Dissemination / methods*
Pandemics
Pneumonia, Viral / drug therapy
Pneumonia, Viral / epidemiology*
Time Factors